There are very few drugs for the management of dementia, such as Cholinesterase inhibitor (Memantine, Galantamine) and an n-cholino receptor which is used to treat the common types dementias like Alzheimer disease & dementia and Vascular Dementia and Parkinson’s disease. Also, these drugs will have an improvement in cognition. Further, this includes Neuroprotective drugs such as nimodipine, propentofylline, and posatirelin presently under study and these may be useful for Vascular Dementia. The Vascular Dementia 2019 also focuses on the advanced drugs for the treatment of Vascular Dementia.
Related Vascular Dementia Conference | Vascular Dementia Congress | Vascular Dementia Events | Vascular Dementia Meetings | Dementia Conference | Dementia Congress | Alzheimer’s Conference | Neurology Conferences | Neuroscience Conferences
6th International Conference on Vascular Dementia Feb 27- Mar 01, 2017 Amsterdam, Netherlands; 11th International Conference on Vascular Dementia July 23-25, 2018 Moscow, Russia; 12th International Conference on Alzheimer’s Disease and Dementia October 29-31, 2018 Valencia, Spain; 9th International Conference and Exhibition on Dementia April 22-23, 2019 Rome, Italy; 12th World Congress on Dementia and Alzheimer Rehabilitation November 27-29, 2018 Athens, Greece; 14th World Summit on Alzheimer’s disease, Dementia Care Research and Awareness Aug 31-Sep 01, Boston Massachusetts, USA; 10th World Congress on Dementia and Alzheimer’s disease Aug 16-18, 2018 Copenhagen, Denmark; 6th International Conference on Neurodegenerative Disorders and Stroke, 5-6 July 2018, Vienna, Austria; 11th FENS Forum of Neuroscience, 7-11 July 2018, Berlin, Germany; Brain and Ocular Nutrition (BON) Conference, 11-13 July 2018, Cambridge University, UK
Related Associations: Alzheimer’s Association; Dementia Society of America; National Stroke Association; Alzheimer’s Society; Stroke Association; Alzheimer’s disease International; Alzheimer’s Research UK; Alzheimer Europe; Age UK; The Alzheimer’s Society of Ireland; Alzheimer Society of Canada; UCL Institute of Neurology; Alzheimer’s Society of Ontario
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
